Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 5/20 | 0.47 |
| ▸ | DRD3 | P35462 | 5/20 | 0.47 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.46 |
| ▸ | JAK2 | O60674 | 1/20 | 0.45 |
| ▸ | JAK3 | P52333 | 1/20 | 0.45 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.45 |
| ▸ | DRD1 | P21728 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | DRD4 | P21917 | 1/20 | 0.42 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15345494 | 0.90 | DRD3 (0.50) | DRD2DRD3ROCK1DRD1SIGMAR1 | |
| SCHEMBL6081885 | 0.77 | MAPT (0.55) | ROCK1SIGMAR1ADRB1SMN1; SMN2ALDH1A1 | |
| SCHEMBL11880068 | 0.75 | ROCK1 (0.50) | ROCK1JAK2JAK3PTK2SIGMAR1 | |
| SCHEMBL10621398 | 0.75 | ROCK1 (0.54) | ROCK1JAK2JAK3PTK2SIGMAR1 | |
| SCHEMBL8332339 | 0.75 | ROCK1 (0.50) | ROCK1JAK2JAK3PTK2HTR2A | |
| SCHEMBL8332463 | 0.74 | SLC6A2 (0.56) | DRD2DRD3CYP2C9CYP2C19 | |
| SCHEMBL10857160 | 0.74 | L3MBTL1 (0.44) | ROCK1POLBSIGMAR1SMN1; SMN2ALDH1A1 | |
| SCHEMBL29652020 | 0.74 | GSK3B (0.50) | ROCK1POLBSIGMAR1SMN1; SMN2ALDH1A1 | |
| SCHEMBL8334755 | 0.73 | MEN1 (0.46) | ROCK1JAK2JAK3PTK2SIGMAR1 | |
| SCHEMBL23917713 | 0.73 | SPR (0.49) | ROCK1SIGMAR1SMN1; SMN2ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210408390-A1 | NOVEL BORON COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | SFC CO., LTD. (KR) | 2021-12-30 | — | — | US | disclosed |
| EP-3885350-A1 | NOVEL BORON COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC Co., Ltd. (KR) | 2021-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210408390-A1 | NOVEL BORON COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | CLTB, CD79B, CYBA | DRD2 103/4885DRD3 160/4885ROCK1 3282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.